DRTS

Alpha Tau Medical Stock Analysis

AI Rating

Fair
  • Quality2/10
  • Growth↓ 0/10
  • Value↑ 6/10
Alpha Tau Medical sales and earnings growth
DRTS Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -17.78%
  • FCF Y/Y↓ -48.75%
Alpha Tau Medical gross and profit margin trends
DRTS Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 0.00%
Alpha Tau Medical net debt vs free cash flow
DRTS Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -196.0

Alpha Tau Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks